 | • レポートコード：MRC2312MG15858 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のメベンダゾール錠市場規模と予測を収録しています。・世界のメベンダゾール錠市場：売上、2018年-2023年、2024年-2029年 ・世界のメベンダゾール錠市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のメベンダゾール錠市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「100mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 メベンダゾール錠のグローバル主要企業は、Johnson & Johnson、 Wellona Pharma、 Arpimed、 AdvaCare、 Anhui Medipharm、 SPMC、 NESTOR、 LEXICARE PHARMA、 NOUVASANTなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、メベンダゾール錠のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のメベンダゾール錠市場：タイプ別、2018年-2023年、2024年-2029年 世界のメベンダゾール錠市場：タイプ別市場シェア、2022年 ・100mg、500mg 世界のメベンダゾール錠市場：用途別、2018年-2023年、2024年-2029年 世界のメベンダゾール錠市場：用途別市場シェア、2022年 ・糸状虫感染症、蟯虫感染症、鞭虫感染症、その他 世界のメベンダゾール錠市場：地域・国別、2018年-2023年、2024年-2029年 世界のメベンダゾール錠市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるメベンダゾール錠のグローバル売上、2018年-2023年 ・主要企業におけるメベンダゾール錠のグローバル売上シェア、2022年 ・主要企業におけるメベンダゾール錠のグローバル販売量、2018年-2023年 ・主要企業におけるメベンダゾール錠のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Johnson & Johnson、 Wellona Pharma、 Arpimed、 AdvaCare、 Anhui Medipharm、 SPMC、 NESTOR、 LEXICARE PHARMA、 NOUVASANT ************************************************************* ・調査・分析レポートの概要 メベンダゾール錠市場の定義 市場セグメント 世界のメベンダゾール錠市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のメベンダゾール錠市場規模 世界のメベンダゾール錠市場規模：2022年 VS 2029年 世界のメベンダゾール錠市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのメベンダゾール錠の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のメベンダゾール錠製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：100mg、500mg メベンダゾール錠のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：糸状虫感染症、蟯虫感染症、鞭虫感染症、その他 メベンダゾール錠の用途別グローバル売上・予測 ・地域別市場分析 地域別メベンダゾール錠市場規模 2022年と2029年 地域別メベンダゾール錠売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Johnson & Johnson、 Wellona Pharma、 Arpimed、 AdvaCare、 Anhui Medipharm、 SPMC、 NESTOR、 LEXICARE PHARMA、 NOUVASANT ... |
This research report provides a comprehensive analysis of the Mebendazole Tablet market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Mebendazole Tablet market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Mebendazole Tablet, challenges faced by the industry, and potential opportunities for market players.
The global Mebendazole Tablet market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Mebendazole Tablet market presents opportunities for various stakeholders, including Threadworm Infection, Pinworm Infection. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Mebendazole Tablet market. Additionally, the growing consumer demand present avenues for market expansion.
The global Mebendazole Tablet market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Mebendazole Tablet market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Mebendazole Tablet market.
Market Overview: The report provides a comprehensive overview of the Mebendazole Tablet market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 100mg, 500mg), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Mebendazole Tablet market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Mebendazole Tablet market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Mebendazole Tablet market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Mebendazole Tablet market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Mebendazole Tablet market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Mebendazole Tablet market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Mebendazole Tablet, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Mebendazole Tablet market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Mebendazole Tablet market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
100mg
500mg
Market segment by Application
Threadworm Infection
Pinworm Infection
Whipworm Infection
Others
Global Mebendazole Tablet Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Johnson & Johnson
Wellona Pharma
Arpimed
AdvaCare
Anhui Medipharm
SPMC
NESTOR
LEXICARE PHARMA
NOUVASANT
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mebendazole Tablet, market overview.
Chapter 2: Global Mebendazole Tablet market size in revenue and volume.
Chapter 3: Detailed analysis of Mebendazole Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mebendazole Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Mebendazole Tablet capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Mebendazole Tablet Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mebendazole Tablet Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mebendazole Tablet Overall Market Size
2.1 Global Mebendazole Tablet Market Size: 2022 VS 2029
2.2 Global Mebendazole Tablet Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Mebendazole Tablet Sales: 2018-2029
3 Company Landscape
3.1 Top Mebendazole Tablet Players in Global Market
3.2 Top Global Mebendazole Tablet Companies Ranked by Revenue
3.3 Global Mebendazole Tablet Revenue by Companies
3.4 Global Mebendazole Tablet Sales by Companies
3.5 Global Mebendazole Tablet Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Mebendazole Tablet Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Mebendazole Tablet Product Type
3.8 Tier 1, Tier 2 and Tier 3 Mebendazole Tablet Players in Global Market
3.8.1 List of Global Tier 1 Mebendazole Tablet Companies
3.8.2 List of Global Tier 2 and Tier 3 Mebendazole Tablet Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Mebendazole Tablet Market Size Markets, 2022 & 2029
4.1.2 100mg
4.1.3 500mg
4.2 By Type – Global Mebendazole Tablet Revenue & Forecasts
4.2.1 By Type – Global Mebendazole Tablet Revenue, 2018-2023
4.2.2 By Type – Global Mebendazole Tablet Revenue, 2024-2029
4.2.3 By Type – Global Mebendazole Tablet Revenue Market Share, 2018-2029
4.3 By Type – Global Mebendazole Tablet Sales & Forecasts
4.3.1 By Type – Global Mebendazole Tablet Sales, 2018-2023
4.3.2 By Type – Global Mebendazole Tablet Sales, 2024-2029
4.3.3 By Type – Global Mebendazole Tablet Sales Market Share, 2018-2029
4.4 By Type – Global Mebendazole Tablet Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Mebendazole Tablet Market Size, 2022 & 2029
5.1.2 Threadworm Infection
5.1.3 Pinworm Infection
5.1.4 Whipworm Infection
5.1.5 Others
5.2 By Application – Global Mebendazole Tablet Revenue & Forecasts
5.2.1 By Application – Global Mebendazole Tablet Revenue, 2018-2023
5.2.2 By Application – Global Mebendazole Tablet Revenue, 2024-2029
5.2.3 By Application – Global Mebendazole Tablet Revenue Market Share, 2018-2029
5.3 By Application – Global Mebendazole Tablet Sales & Forecasts
5.3.1 By Application – Global Mebendazole Tablet Sales, 2018-2023
5.3.2 By Application – Global Mebendazole Tablet Sales, 2024-2029
5.3.3 By Application – Global Mebendazole Tablet Sales Market Share, 2018-2029
5.4 By Application – Global Mebendazole Tablet Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Mebendazole Tablet Market Size, 2022 & 2029
6.2 By Region – Global Mebendazole Tablet Revenue & Forecasts
6.2.1 By Region – Global Mebendazole Tablet Revenue, 2018-2023
6.2.2 By Region – Global Mebendazole Tablet Revenue, 2024-2029
6.2.3 By Region – Global Mebendazole Tablet Revenue Market Share, 2018-2029
6.3 By Region – Global Mebendazole Tablet Sales & Forecasts
6.3.1 By Region – Global Mebendazole Tablet Sales, 2018-2023
6.3.2 By Region – Global Mebendazole Tablet Sales, 2024-2029
6.3.3 By Region – Global Mebendazole Tablet Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Mebendazole Tablet Revenue, 2018-2029
6.4.2 By Country – North America Mebendazole Tablet Sales, 2018-2029
6.4.3 US Mebendazole Tablet Market Size, 2018-2029
6.4.4 Canada Mebendazole Tablet Market Size, 2018-2029
6.4.5 Mexico Mebendazole Tablet Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Mebendazole Tablet Revenue, 2018-2029
6.5.2 By Country – Europe Mebendazole Tablet Sales, 2018-2029
6.5.3 Germany Mebendazole Tablet Market Size, 2018-2029
6.5.4 France Mebendazole Tablet Market Size, 2018-2029
6.5.5 U.K. Mebendazole Tablet Market Size, 2018-2029
6.5.6 Italy Mebendazole Tablet Market Size, 2018-2029
6.5.7 Russia Mebendazole Tablet Market Size, 2018-2029
6.5.8 Nordic Countries Mebendazole Tablet Market Size, 2018-2029
6.5.9 Benelux Mebendazole Tablet Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Mebendazole Tablet Revenue, 2018-2029
6.6.2 By Region – Asia Mebendazole Tablet Sales, 2018-2029
6.6.3 China Mebendazole Tablet Market Size, 2018-2029
6.6.4 Japan Mebendazole Tablet Market Size, 2018-2029
6.6.5 South Korea Mebendazole Tablet Market Size, 2018-2029
6.6.6 Southeast Asia Mebendazole Tablet Market Size, 2018-2029
6.6.7 India Mebendazole Tablet Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Mebendazole Tablet Revenue, 2018-2029
6.7.2 By Country – South America Mebendazole Tablet Sales, 2018-2029
6.7.3 Brazil Mebendazole Tablet Market Size, 2018-2029
6.7.4 Argentina Mebendazole Tablet Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Mebendazole Tablet Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Mebendazole Tablet Sales, 2018-2029
6.8.3 Turkey Mebendazole Tablet Market Size, 2018-2029
6.8.4 Israel Mebendazole Tablet Market Size, 2018-2029
6.8.5 Saudi Arabia Mebendazole Tablet Market Size, 2018-2029
6.8.6 UAE Mebendazole Tablet Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Mebendazole Tablet Major Product Offerings
7.1.4 Johnson & Johnson Mebendazole Tablet Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Wellona Pharma
7.2.1 Wellona Pharma Company Summary
7.2.2 Wellona Pharma Business Overview
7.2.3 Wellona Pharma Mebendazole Tablet Major Product Offerings
7.2.4 Wellona Pharma Mebendazole Tablet Sales and Revenue in Global (2018-2023)
7.2.5 Wellona Pharma Key News & Latest Developments
7.3 Arpimed
7.3.1 Arpimed Company Summary
7.3.2 Arpimed Business Overview
7.3.3 Arpimed Mebendazole Tablet Major Product Offerings
7.3.4 Arpimed Mebendazole Tablet Sales and Revenue in Global (2018-2023)
7.3.5 Arpimed Key News & Latest Developments
7.4 AdvaCare
7.4.1 AdvaCare Company Summary
7.4.2 AdvaCare Business Overview
7.4.3 AdvaCare Mebendazole Tablet Major Product Offerings
7.4.4 AdvaCare Mebendazole Tablet Sales and Revenue in Global (2018-2023)
7.4.5 AdvaCare Key News & Latest Developments
7.5 Anhui Medipharm
7.5.1 Anhui Medipharm Company Summary
7.5.2 Anhui Medipharm Business Overview
7.5.3 Anhui Medipharm Mebendazole Tablet Major Product Offerings
7.5.4 Anhui Medipharm Mebendazole Tablet Sales and Revenue in Global (2018-2023)
7.5.5 Anhui Medipharm Key News & Latest Developments
7.6 SPMC
7.6.1 SPMC Company Summary
7.6.2 SPMC Business Overview
7.6.3 SPMC Mebendazole Tablet Major Product Offerings
7.6.4 SPMC Mebendazole Tablet Sales and Revenue in Global (2018-2023)
7.6.5 SPMC Key News & Latest Developments
7.7 NESTOR
7.7.1 NESTOR Company Summary
7.7.2 NESTOR Business Overview
7.7.3 NESTOR Mebendazole Tablet Major Product Offerings
7.7.4 NESTOR Mebendazole Tablet Sales and Revenue in Global (2018-2023)
7.7.5 NESTOR Key News & Latest Developments
7.8 LEXICARE PHARMA
7.8.1 LEXICARE PHARMA Company Summary
7.8.2 LEXICARE PHARMA Business Overview
7.8.3 LEXICARE PHARMA Mebendazole Tablet Major Product Offerings
7.8.4 LEXICARE PHARMA Mebendazole Tablet Sales and Revenue in Global (2018-2023)
7.8.5 LEXICARE PHARMA Key News & Latest Developments
7.9 NOUVASANT
7.9.1 NOUVASANT Company Summary
7.9.2 NOUVASANT Business Overview
7.9.3 NOUVASANT Mebendazole Tablet Major Product Offerings
7.9.4 NOUVASANT Mebendazole Tablet Sales and Revenue in Global (2018-2023)
7.9.5 NOUVASANT Key News & Latest Developments
8 Global Mebendazole Tablet Production Capacity, Analysis
8.1 Global Mebendazole Tablet Production Capacity, 2018-2029
8.2 Mebendazole Tablet Production Capacity of Key Manufacturers in Global Market
8.3 Global Mebendazole Tablet Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Mebendazole Tablet Supply Chain Analysis
10.1 Mebendazole Tablet Industry Value Chain
10.2 Mebendazole Tablet Upstream Market
10.3 Mebendazole Tablet Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Mebendazole Tablet Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer